Literature DB >> 20395015

APOE ε4 is associated with longer telomeres, and longer telomeres among ε4 carriers predicts worse episodic memory.

Mikael Wikgren1, Thomas Karlsson, Therese Nilbrink, Katarina Nordfjäll, Johan Hultdin, Kristel Sleegers, Christine Van Broeckhoven, Lars Nyberg, Göran Roos, Lars-Göran Nilsson, Rolf Adolfsson, Karl-Fredrik Norrback.   

Abstract

Both leukocyte telomere length and the apolipoprotein ε4 allele have been associated with mortality, cardiovascular disease, cognition, and dementia. The authors investigated whether leukocyte telomere length was associated with APOE genotype or cognitive abilities in the context of APOE genotype. The setting for this cross-sectional study was 427 nondemented individuals aged 41-81 yr. The authors found that ε4 carriers overall exhibited significantly longer telomeres compared with non-carriers (difference of 268 bp, p = 0.001). This difference was greatest at the lower limit of the age span and nonsignificant at the upper limit, which translated into a significantly higher telomere attrition rate (p = 0.049) among ε4 carriers (37 bp/years) compared with non-carriers (21 bp/year). Further, longer telomeres among ε4 carriers significantly predicted worse performance on episodic memory tasks. No significant associations were found on tasks tapping semantic and visuospatial ability, or among ε3/ε3 carriers. In conclusion, APOE ε4 carriers had longer telomeres compared with non-carriers, but higher rate of attrition. Among them, longer telomeres predicted worse performance on episodic memory tasks. These observations suggest that the ε4 allele is associated with abnormal cell turnover of functional and possibly clinical significance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395015     DOI: 10.1016/j.neurobiolaging.2010.03.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

1.  Short and long telomeres increase risk of amnestic mild cognitive impairment.

Authors:  Rosebud O Roberts; Lisa A Boardman; Ruth H Cha; V Shane Pankratz; Ruth A Johnson; Brooke R Druliner; Teresa J H Christianson; Lewis R Roberts; Ronald C Petersen
Journal:  Mech Ageing Dev       Date:  2014-10-22       Impact factor: 5.432

Review 2.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

3.  Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants.

Authors:  Adiba Ashrafi; Stephanie Cosentino; Min S Kang; Joseph H Lee; Nicole Schupf; Stacy L Andersen; Kaare Christensen; Michael A Province; Bharat Thyagarajan; Joseph M Zmuda; Lawrence S Honig
Journal:  J Int Neuropsychol Soc       Date:  2020-04-28       Impact factor: 2.892

4.  Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline.

Authors:  Jue Lin; Candyce H Kroenke; Elissa Epel; Heather A Kenna; Owen M Wolkowitz; Elizabeth Blackburn; Natalie L Rasgon
Journal:  Brain Res       Date:  2010-10-18       Impact factor: 3.252

5.  Effect of leukocyte telomere length on total and regional brain volumes in a large population-based cohort.

Authors:  Kevin S King; Julia Kozlitina; Roger N Rosenberg; Ronald M Peshock; Roderick W McColl; Christine K Garcia
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

6.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

7.  Meta-analysis of Telomere Length in Alzheimer's Disease.

Authors:  Diego A Forero; Yeimy González-Giraldo; Catalina López-Quintero; Luis J Castro-Vega; George E Barreto; George Perry
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-04-18       Impact factor: 6.053

8.  Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.

Authors:  Emily G Jacobs; Candyce Kroenke; Jue Lin; Elissa S Epel; Heather A Kenna; Elizabeth H Blackburn; Natalie L Rasgon
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Longer leukocyte telomere length is associated with smaller hippocampal volume among non-demented APOE ε3/ε3 subjects.

Authors:  Mikael Wikgren; Thomas Karlsson; Johanna Lind; Therese Nilbrink; Johan Hultdin; Kristel Sleegers; Christine Van Broeckhoven; Göran Roos; Lars-Göran Nilsson; Lars Nyberg; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

10.  Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.

Authors:  Fernanda Schäfer Hackenhaar; Maria Josefsson; Annelie Nordin Adolfsson; Mattias Landfors; Karolina Kauppi; Magnus Hultdin; Rolf Adolfsson; Sofie Degerman; Sara Pudas
Journal:  Alzheimers Res Ther       Date:  2021-07-15       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.